ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Positive feedback regulation of lncRNA TPT1-AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer

Cheng, Chundong; Liu, Danxi; Liu, Zonglin; Li, Mengyang; Wang, Yongwei*; Sun, Bei*; Kong, Rui; Chen, Hua; Wang, Gang; Li, Le; Hu, Jisheng; Li, Yilong; Chen, Hongze; Zhao, Zhongjie; Zhang, Tao; Zhu, Siqiang; Pan, Shangha哈尔滨医科大学; 1
Cancer Science2022-9DOI: 10.1111/cas.15388
9被引7阅读
引用收藏
分享

摘要

Emerging evidence has indicated that long noncoding RNAs (lncRNAs) are potential biomarkers and play crucial roles in cancer development. However, the functions and underlying mechanisms of lncRNA TPT1-AS1 in pancreatic ductal adenocarcinoma (PDAC) remain elusive. RNAseq data of PDAC tissues and normal tissues were analyzed, and lncRNAs which were associated with PDAC prognosis were identified. The clinical relevance of TPT1-AS1 for PDAC patients was explored, and the effects of TPT1-AS1 in PDAC progression were investigated in vitro and in vivo. LncRNA TPT1-AS1 was highly expressed in PDAC, and high TPT1-AS1 levels predicted a poor prognosis. Moreover, functional experiments revealed that TPT1-AS1 promoted pancreatic cancer cell proliferation, migration, invasion, and epithelial-to-mesenchymal transition (EMT) process in vitro and in vivo. Mechanistically, TPT1-AS1 functioned as an endogenous sponge for miR-30a-5p, which increased integrin beta 3 (ITGB3) level in pancreatic cancer cells. Conversely, our data revealed that ITGB3 could activate the transcription factor signal transducer and activator of transcription 3 (STAT3), which in turn bound directly to the TPT1-AS1 promoter and affected the expression of TPT1-AS1, thus forming a positive feedback loop with TPT1-AS1. Taken together, our results uncovered a reciprocal loop of TPT1-AS1 and ITGB3 which contributed to pancreatic cancer growth and development, and indicated that TPT1-AS1 might serve as a novel potential diagnostic biomarker and therapeutic target for PDAC patients.

学科与关键词

关键词
ITGB3miR-30a-5ppancreatic cancerSTAT3TPT1-AS1
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cancer Science
发表日期
2022-09
卷期
第 113 卷, 第 9 期
页码
2986-3001
DOI
10.1111/cas.15388
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Excellent Young Medical Talents Training Fund of the First Affiliated Hospital of Harbin Medical University [HYD2020YQ0010]; National Nature Scientific Foundation of China [81702384, 81372613, 81670583, 81800572]; Heilongjiang Postdoctoral Scientific Research Developmental Fund [LBH-Q20142]; Innovative Young Talents Training Scheme for General Undergraduate Higher Education Institutions in Heilongjiang [UNPYSCT-2016188]

作者

  • C

    Cheng, Chundong (第一作者)

    1 · harbin med univ

  • L

    Liu, Danxi

    1 · harbin med univ

查看全部 17 位作者收起作者
  • L

    Liu, Zonglin

    1 · harbin med univ

  • L

    Li, Mengyang

    1 · harbin med univ

  • W

    Wang, Yongwei (通讯)

    1 · harbin med univ

  • S

    Sun, Bei (通讯)

    1 · harbin med univ

  • K

    Kong, Rui

    1 · harbin med univ

  • C

    Chen, Hua

    1 · harbin med univ

  • W

    Wang, Gang

    1 · harbin med univ

  • L

    Li, Le

    1 · harbin med univ

  • H

    Hu, Jisheng

    1 · harbin med univ

  • L

    Li, Yilong

    1 · harbin med univ

  • C

    Chen, Hongze

    1 · harbin med univ

  • Z

    Zhao, Zhongjie

    1 · harbin med univ

  • Z

    Zhang, Tao

    1 · harbin med univ

  • Z

    Zhu, Siqiang

    1 · harbin med univ

  • P

    Pan, Shangha

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417